Novavax Announces $27 Million Equity Offering
23 oct. 2012 16h42 HE
|
Novavax, Inc.
ROCKVILLE, Md., Oct. 23, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it has raised a total of $27 million through the sale of 12,285,321 shares of its common stock to RA...
Novavax Reports Positive Top-Line Results From Two Phase 1 Trials of Pandemic Influenza Vaccine
17 oct. 2012 16h01 HE
|
Novavax, Inc.
Vaccine candidates met safety and immunogenicity endpoints in both trials
Trials' results support further development of vaccine in larger trials
-- Adjuvanted candidates, at all doses of...
Novavax Initiates Phase 1 Clinical Trial of RSV Vaccine Candidate in Elderly Adults
15 oct. 2012 16h04 HE
|
Novavax, Inc.
ROCKVILLE, Md., Oct. 15, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that enrollment has begun in a Phase 1 dose-ranging clinical trial of its respiratory syncytial virus...
Novavax Initiates Phase 2 Clinical Trial of RSV Vaccine Candidate
08 oct. 2012 13h34 HE
|
Novavax, Inc.
ROCKVILLE, Md., Oct. 8, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that enrollment has begun in a Phase 2 dose-ranging clinical trial of its respiratory syncytial virus (RSV)...
Novavax Presents RSV Vaccine Data at the 8th Annual International Respiratory Virus Symposium
27 sept. 2012 08h00 HE
|
Novavax, Inc.
Data Reinforce Previous Clinical and Preclinical Studies
Successfully Induced F-Protein Specific Neutralizing Antibody Response
Phase 2 Studies to Begin in the Fourth Quarter of...
NOVAVAX to Present at the Rodman & Renshaw 14th Annual Healthcare Conference
06 sept. 2012 13h50 HE
|
Novavax, Inc.
ROCKVILLE, Md., Sept. 6, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
NOVAVAX to Present at the 2012 Stifel Nicolaus Healthcare Conference
04 sept. 2012 10h28 HE
|
Novavax, Inc.
ROCKVILLE, Md., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
NOVAVAX to Present at the 2012 Wedbush Life Sciences Conference
13 août 2012 11h05 HE
|
Novavax, Inc.
ROCKVILLE, Md., Aug. 13, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
NOVAVAX Reports Second Quarter 2012 Financial Results
03 août 2012 08h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., Aug. 3, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced its financial results for the second quarter and six months ended June 30, 2012.
Second Quarter 2012 and...
NOVAVAX to Report Second Quarter 2012 Financial Results on August 3, 2012
27 juil. 2012 09h00 HE
|
Novavax, Inc.
ROCKVILLE, Md., July 27, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report its 2012 second-quarter financial results on Friday, August 3, 2012, before the U.S....